Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Staelens

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Nuclear Medicine and Biology|January 9, 2026
Rodent biodistribution and dosimetry of the PET radioligands [<sup>18</sup>F]CHDI-385 and [<sup>18</sup>F]CHDI-386 targeting mutant huntingtin aggregatesJordy Akkermans, Alan Miranda, Jeroen Verhaeghe, et al.
Nuclear Medicine and Biology|April 29, 2014
In vivo evaluation of (18)F-labeled TCO for pre-targeted PET imaging in the brainLeonie Wyffels, David Thomae, Ann-Marie Waldron, et al.
BMC Neurology|November 14, 2018
The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: a water PET and EEG imaging studyShaheen Ahmed, Mark Plazier, Jan Ost, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
SV2A PET Imaging Detects Severity-Dependent Synaptic Changes After Experimental Traumatic Spinal Cord InjuryClaudia Schrauwen, Nicolas Halloin, Annemie Van Eetveldt, et al.
Nuclear Medicine and Biology|April 29, 2014
Synthesis and in vivo preclinical evaluation of an (18)F labeled uPA inhibitor as a potential PET imaging agentJohan Ides, David Thomae, Leonie Wyffels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
In Vivo PET Imaging of [<sup>18</sup>F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington DiseaseFranziska Zajicek, Filipe Elvas, Alan Miranda, et al.
Pharmaceutical Research|March 23, 2011
Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat modelWim Bouquet, Steven Deleye, Steven Staelens, et al.
Molecular Imaging and Biology|December 4, 2019
In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [<sup>11</sup>C]ITDM in MiceDaniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
ACS Omega|March 17, 2020
Preclinical Evaluation of a Novel <sup>18</sup>F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography ImagingEduardo Ruivo, Filipe Elvas, Karuna Adhikari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease PostmortemDaniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Nuclear Medicine and Biology|January 9, 2026
Rodent biodistribution and dosimetry of the PET radioligands [<sup>18</sup>F]CHDI-385 and [<sup>18</sup>F]CHDI-386 targeting mutant huntingtin aggregatesJordy Akkermans, Alan Miranda, Jeroen Verhaeghe, et al.
Nuclear Medicine and Biology|April 29, 2014
In vivo evaluation of (18)F-labeled TCO for pre-targeted PET imaging in the brainLeonie Wyffels, David Thomae, Ann-Marie Waldron, et al.
BMC Neurology|November 14, 2018
The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: a water PET and EEG imaging studyShaheen Ahmed, Mark Plazier, Jan Ost, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2026
SV2A PET Imaging Detects Severity-Dependent Synaptic Changes After Experimental Traumatic Spinal Cord InjuryClaudia Schrauwen, Nicolas Halloin, Annemie Van Eetveldt, et al.
Nuclear Medicine and Biology|April 29, 2014
Synthesis and in vivo preclinical evaluation of an (18)F labeled uPA inhibitor as a potential PET imaging agentJohan Ides, David Thomae, Leonie Wyffels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
In Vivo PET Imaging of [<sup>18</sup>F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington DiseaseFranziska Zajicek, Filipe Elvas, Alan Miranda, et al.
Pharmaceutical Research|March 23, 2011
Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat modelWim Bouquet, Steven Deleye, Steven Staelens, et al.
Molecular Imaging and Biology|December 4, 2019
In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [<sup>11</sup>C]ITDM in MiceDaniele Bertoglio, Jeroen Verhaeghe, Špela Korat, et al.
ACS Omega|March 17, 2020
Preclinical Evaluation of a Novel <sup>18</sup>F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography ImagingEduardo Ruivo, Filipe Elvas, Karuna Adhikari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease PostmortemDaniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.
Pageof 17